| Literature DB >> 24031215 |
I L B C Camargo1, R C Zanella, M S Gilmore, A L C Darini.
Abstract
Enterococci are members of commensal flora of animals and insects, but are also important opportunistic pathogens. Our objective was to observe if there was any difference of virulence in several groups of E. faecalis, mainly between vancomycin-resistant E. faecalis (VREFS) of colonization and infection. VREFS and vancomycin-sensitive E. faecalis from Brazil were screened for the presence of virulence factor genes. Phenotypic assays were used to assess in vitro expression, to understand the pathogenic potential of these isolates and to determine whether a correlation exists between virulence and antibiotic resistance. Different virulence profiles were found suggesting that the disseminating clone may have generated several variations. However, our study showed that one constellation of traits appeared most commonly: gelatinase, aggregation substance and esp (GEA). These factors are important because they have been implicated in cell aggregation and biofilm formation. Biofilm formation may promote the conjugation of plasmids harboring resistance and virulence genes, enhancing the probability of entry of new resistance genes into species. Curiously, the profile GEA was not exclusive to VREFS, it was the second most observed in VSEFS isolates from colonization and infection in hospitalized patients and also from rectal swabs of healthy volunteers. Such strains appear to represent the entry gateway to new resistance genes into E. faecalis and may contribute to the spreading of E. faecalis mainly in hospitals.Entities:
Keywords: Enterococcus faecalis; Esp; VRE; aggregation substance; gelatinase
Year: 2008 PMID: 24031215 PMCID: PMC3768389 DOI: 10.1590/S1517-838220080002000014
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Primers used to make the specific probes for hybridization.
| Gene | Primer name | Sequence 5’-3’ | Lenght of the fragment | Reference |
|---|---|---|---|---|
| cylLL | cylLL F | AAC TAA GTG TTG AGG AAA TG | 159bp | ( |
| cylLL R | AAA GAC ACA ACT ACA GTT AC | |||
| cylLs | cylLs F | AGA ACTTGT TGG TCC TTC | 134 bp | ( |
| cylLs R | GCT GAA AAT AAT GCA CCT AC | |||
| cylA | cylA F | ACA GGT TAT GCA TCA GAT CT | 507bp | ( |
| cylA R | AAT TCA CTC TTG GAG CAA TC | |||
| esp | Esp14F | AGATTTCAT CTTTGATTCTTG G | 500 bp | AF034779 |
| Esp12R | AAT TGA TTC TTT AGC ATC TGG | |||
| gelE | gelE F | AATTGCTTTACACGGAACGG | 548bp | ( |
| gelE R | GAGCCATGGTTTCTGGTTGT | |||
| Agg 1 | Agg 1 F | AGT GAC GAT TGA TTTATC CAA AGT G | 446bp | X17214and |
| (asa1 and asc 10 ) | M64978 | |||
| Agg 1 R | CGT TCG GAA GAT TTC ACT TCA TAA T |
The primers were designed based on the sequences registered in the GenBank.
The sequences of esp primers were provided by Dr. Nathan Shankar, College of Pharmacy, Oklahoma University Health Sciences Center, OK, USA.
Primers are the same for amplify both genes, but the templates were different.
Date, susceptibility profile, virulence factors and PFGE profile present in vancomycin-resistant E.faecalis isolates from Brazil.
| Samples | Isolation | Virulence factors | Susceptibility profile | PFGE profile | |
|---|---|---|---|---|---|
| Date | Source | Genes | P /HLAR G /HLAR S | ||
| VREFS chp | |||||
| 4 | 1998 | CSSM-SP | R/R/S | A2 | |
| 5 | 1998 | CSSM-SP | R/R/S | A | |
| 6 | 1998 | CSSM-SP | R/R/S | A | |
| 18 | 1999 | HCSP-SP | R/R/S | A | |
| 22 | 2000 | HCASP-SP | R/R/S | A | |
| 24 | 1998 | CSSM-SP | R/R/S | C | |
| 17 | 1999 | CSSM-SP | R/R/S | A | |
| 23 | 1999 | HSPSP-SP | R/S/S | A | |
| VREFS ihp | |||||
| 1 | 1998 | CSSM-SP | R/R/S | B | |
| 2 | 1998 | CSSM-SP | R/R/S | A | |
| 3 | 1998 | CSSM-SP | R/R/S | A1 | |
| 7 | 2000 | HEDPA - RS | R/R/S | A1 | |
| 8 | 2000 | HPUCP-RS | R/R/S | A | |
| 9 | 2000 | HCC-PR | R/R/S | A2 | |
| 10 | 2000 | HCC-PR | R/R/S | A3 | |
| 11 | 1999 | CSSM-SP | R/R/S | A | |
| 12 | 1999 | CSSM-SP | R/R/S | A | |
| 13 | 1999 | CSSM-SP | R/R/S | A | |
| 14 | 1999 | CSSM-SP | R/R/S | A | |
| 15 | 1999 | CSSM-SP | R/R/S | A | |
| 16 | 1999 | CSSM-SP | R/R/S | A | |
| 20 | 2000 | CSSM-SP | R/R/S | A | |
| 21 | 1999 | HSPSP-SP | R/R/S | A | |
| 25 | 2003 | UFU - MG | R/R/S | A4 | |
CSSM-SP - Casa de Saude Santa Marcelina - SP, HCSP-SP- Hospital do Coração de São Paulo, HSPSP-SP - Hospital do Servidor Público de São Paulo, HED PA - RS- Hospital Ernesto Dornelles - Porto Alegre - RS, HPUCPA - RS- Hospital da Pontificia Universidade Católica de Porto Alegre - RS, HCC-PR - Hospital das Cllnicas de Curitiba - PR, HCASP-SP - Hospital Cruz Azul - SP, UFU - MG, Universidade Federal de Uberlandia.
gelE, gelatinase gene; cylL, cytolysin genes; asa1 and asc10 are aggregation substance’s genes; esp, enterococcal surfae protein gene.
G, gelatinase, A, aggregation, E, esp presence, C, cytolysin activity, N, none of the virulence factors studied found were expressed.
P, penicillin, HLAR G, high level aminoglycoside resistance - gentamycin, HLAR S, high level Aminoglycoside resistance - streptomycin, R, resistant and S, susceptible.
chp, isolates of hospitalized colonization patients.
ihp, isolates of infection in hospitalized patients.
Figure 1Agarose gel electrophoresis of genomic DNA. a) Results of pulsed-field Gel electrophoresis analysis of VREFS isolated in Brazil. 1- M, Lambda PFMarker (New England BioLabs), 2- VREFS ihp 13, 3- VREFS chp 5, 4- VREFS chp 18, 5- VREFS chp 22, 6- VREFS ihp 8, 7- VREFS chp 17, 8- VREFS ihp 7, 9- VREFS ihp 9, 10- VREFS chp 4, 11- VREFS ihp 25, 12- VREFS ihp 1, 13- M Lambda PFMarker (New England BioLabs); b) Dendrogram of PFGE of the strains calculated with percent similarity performed by MVSP 3.0 software. chp, isolates of hospitalized and colonized patients; ihp, isolates from infection in hospitalized patients.